Results 11 to 20 of about 159,674 (308)

Venoms, venomics, antivenomics [PDF]

open access: yesFEBS Letters, 2009
Venoms comprise mixtures of peptides and proteins tailored by Natural Selection to act on vital systems of the prey or victim. Here we review our proteomic protocols for uncoiling the composition, immunological profile, and evolution of snake venoms. Our long‐term goal is to gain a deep insight of all viperid venom proteomes.
Calvete Chornet, Juan José   +4 more
openaire   +4 more sources

Hymenoptera Allergens: From Venom to “Venome” [PDF]

open access: yesFrontiers in Immunology, 2014
In Western Europe, Hymenoptera venom allergy (HVA) primarily relates to venoms of the honeybee and the common yellow jacket. In contrast to other allergen sources, only a few major components of Hymenoptera venoms had been characterized until recently.
Spillner, Edzard   +2 more
openaire   +5 more sources

Clinical effectiveness of hymenoptera venom immunotherapy [PDF]

open access: yes, 2013
Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters with the frequency of VIT failure during ...
Scheipl, Fabian   +21 more
core   +1 more source

On the occurrence of Persian Gulf Sea Snake, Hydrophis lapemoides (Gray, 1849) (Reptilia, Squamata, Elapidae, Hydrophiinae), along the coast of Bangladesh [PDF]

open access: yesCheck List, 2021
We provide the first evidence of the presence of the Persian Gulf Sea Snake, Hydrophis lapemoides (Gray, 1849), along the coast of Bangladesh. This species was assumed to exist in there, but neither specimens nor confirmed observations exist until now ...
Mohammad Abdul Wahed Chowdhury   +5 more
doaj   +3 more sources

Pharmacological aspects of Vipera xantina palestinae venom [PDF]

open access: yes, 2011
In Israel, Vipera xantina palestinae (V.x.p.) is the most common venomous snake, accounting for several hundred cases of envenomation in humans and domestic animals every year, with a mortality rate of 0.5 to 2%.
Katzhendler, Jeoshua   +14 more
core   +1 more source

Comparative Studies of the Venom of a New Taipan Species, Oxyuranus temporalis, with Other Members of Its Genus

open access: yesToxins, 2014
Taipans are highly venomous Australo-Papuan elapids. A new species of taipan, the Western Desert Taipan (Oxyuranus temporalis), has been discovered with two specimens housed in captivity at the Adelaide Zoo.
Carmel M. Barber   +8 more
doaj   +1 more source

Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Objective(s): One of the important interactions in controlling the human immune system is the reaction between checkpoint proteins such as programmed cell death-1 (PD-1) and its ligand, PD-L1.
Akbar Oghalaei   +9 more
doaj   +1 more source

Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms [PDF]

open access: yes, 2002
Background: Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to examine the characteristics of allergic reactions during Rush-SIT in a ...
Mingomataj, Ervin   +6 more
core   +1 more source

Kinome scale profiling of venom effects on cancer cells reveals potential new venom activities [PDF]

open access: yes, 2020
The search for novel and relevant cancer therapeutics is continuous and ongoing. Cancer adaptations, resulting in therapeutic treatment failures, fuel this continuous necessity for new drugs to novel targets.
Knight, E.   +4 more
core   +1 more source

Bacterial adaptation to venom in snakes and arachnida [PDF]

open access: yes, 2022
Notwithstanding their 3 to 5% mortality, the 2.7 million envenomation-related injuries occurring annually—predominantly across Africa, Asia, and Latin America—are also major causes of morbidity.
Trim, Carol   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy